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Aims: The aim of the present study was to evaluate the correlation between matrix 
  metalloproteinase-9 (MMP-9) and chondroitin sulfate (CS) concentrations in human tear fluid 
following laser in situ keratomileusis (LASIK).
Methods: Twelve eyes from six patients who had no ocular complaints except for   refractive 
errors, and who had undergone LASIK, were enrolled in this study. We measured the 
  concentrations of chondroitin 4 sulfate (C4S), chondroitin 6 sulfate (C6S), and MMP-9 activity 
with an enzyme-linked immunosorbent assay and an enzyme immunocapture activity assay 
preoperatively and postoperatively on days 1 and 4, week 1, and at 1 and 3 months.
Results: Although the preoperative MMP-9 activity and the C4S concentration were 
highly correlated (r = 0.900; P , 0.001), they were not postoperatively correlated at 
month 1. Although the preoperative MMP-9 activity and the C6S concentration were highly 
  correlated (r = 0.885; P , 0.001), they were not postoperatively correlated at either week 
1 or months 1 and 3.
Conclusions: The correlation appeared to be collapsed by LASIK, and it did not recover to 
the preoperative score at 3 months post-surgery. Our study indicates that the corneal wound 
healing was not terminated at 3 months following LASIK.
Keywords: preoperative correlation, postoperative correlation, wound healing, refractive 
errors, human cornea
Introduction
By degenerating superfluous extracellular matrix,1 matrix metalloproteinases (MMPs) 
play an important role in tissue remodeling and wound healing.2 In the ophthalmologic 
area, MMPs also play an important role in corneal wound healing,3 and more than 
28 subtypes have been identified thus far.4
Chondroitin sulfate (CS), a type of glycosaminoglycan, exists in various organs and 
is essential for corneal wound healing.5–7 Chondroitin 4 sulfate (C4S) and chondroitin 
6 sulfate (C6S) are sulfated isomers.5–7 The majority of the glycosaminoglycans in the 
tear fluid are CS6. Both MMPs and CS are detectable in human tear fluid.1,5,6,8 Matrix 
metalloproteinase-9 (MMP-9) was found to be expressed in corneal wound healing in 
animal experiments9,10 and CS participates in corneal wound healing after laser in situ 
keratomileusis (LASIK) as assessed in a clinical study.5 CS increased MMPs activity in 
corneal explant   cultures.11 MMP-9 and CS deeply participate in corneal ectasia which 
occurred several years after LASIK.12 Based on the findings of these previous reports, Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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we therefore consider the relationship between MMP-9 and 
CS to be very important in corneal wound healing.
By measuring the levels of MMP-9 activity and the 
  concentrations of C4S and C6S in human tear fluid from 
patients undergoing myopic or myopic astigmatic LASIK, we 
evaluated whether MMP-9 activity is postoperatively corre-
lated with the C4S and C6S concentrations up to 3 months.
Materials and methods
The protocol of this study was approved by the institutional 
review board of the Dokkyo Medical University, and all 
participating patients provided written informed consent.
Twelve eyes of six patients who underwent myopic or 
myopic astigmatic LASIK were included in the present 
study (mean age ± standard deviation, 30.0 ± 6.4 years). 
The patients had no ocular complaints except for the refrac-
tive errors, and they had not undergone any previous ocular 
surgery.
LASIK
Simultaneous binocular LASIK was performed in all patients. 
The VISXR Star S3 excimer laser (VISX USA Inc., Santa 
Clara, CA, USA); wavelength, 193 nm; fluence, 160 mJ/cm2; 
pulse rate,10 Hz and the Moria LASIK M2 microkeratome 
(Moria KK, Tokyo, Japan) were used. The eye tracking system 
of the excimer laser was activated during the procedure.
A corneal flap was created using the microkeratome and 
was then lifted. The planned laser ablation was performed 
on the corneal stroma; the corneal flap and stromal bed then 
were washed using 0.3 mM oxyglutathione solution. The 
corneal flap was returned to the original position and spon-
taneously reattached. After the procedure, 0.5% levofloxacin 
and 0.1% betamethasone sodium phosphate were bilaterally 
instilled. The patients then applied 0.5% levofloxacin, 0.1% 
fluorometholone, and 0.3% sodium hyaluronate 4 times daily 
for 1 week after surgery. One week later, 0.5% levofloxacin 
and 0.1% fluorometholone were tapered to twice daily and 
discontinued 1 month postoperatively, and 0.3% sodium 
hyaluronate was applied as needed.
Sampling tear fluid
Tear fluid was collected from the lower conjunctival sac with 
a microcapillary tube (Minicaps, Hirschmann Laborgerate, 
Osaka, Japan); capillary length, 32 mm; maximum volume, 
0.5 µL). We did not touch the conjunctiva to prevent con-
junctival stimulation and reflex tearing. The collection time 
was 30 s. When the capillary filled with tear fluid within 
30 s, additional capillaries were immediately applied to the 
conjunctival sac until 30 s. No topical anesthesia was applied 
during the collection process, and no topical agents were used 
within 30 min before the collection of the tear fluid. The tear 
volume was calculated by measuring the height of the tear 
fluid in the microcapillary tube. We collected 0.3 to 3 µL of 
tear fluid from each patient and formulated the samples by 
diluting the collected tear fluid with 200 µL of saline. The 
samples were frozen immediately at -40 after collection 
until the measurements were performed. Tear fluid was pre-
operatively collected and postoperatively on days 1 and 4, 
at 1 week, and 1 and 3 months. All samples were collected 
by the same investigator.
MMP-9 specific enzyme immunocapture 
activity assay
The concentrations of each CS isomer in the tear fluid were 
measured by a sandwich enzyme-linked immunosorbent 
assay, as reported previously.5 The MMP-9 activity was mea-
sured with enzyme immunocapture activity assay (Biotrak 
Matrix Metalloproteinase-9 Activity Assay System, GE 
Healthcare Bio-Sciences KK, Tokyo, Japan).
The 20-µL samples and MMP-9 standard solution were 
placed in the wells of microplates that were precoated with 
anti-MMP-9 antibody, reacted, fixed at 4°C overnight, 
and immunocaptured. After washing, active MMP-9 was 
detected through the activation of the modified pro-detection 
enzyme and subsequent cleavage of its chromogenic peptide 
substrate. The resulting coloration was read at 405 nm in a 
microtitre plate spectrophotometer (Spectra Fluor, Xfluor 
ver.4.03, Tecan Austria GmbH, Grödig, Austria). The con-
centration of active MMP-9 in a sample was determined by 
interpolation from a standard curve.13
Statistical analysis
The MMP-9 activity and the concentrations of CS isomers 
in the tear fluid were analyzed by Pearson’s product-moment 
correlation. P-values of less than 0.05 were considered to be 
statistically significant using Fisher’s r to z transformation.
Results
The uncorrected distance visual acuity recovered to 1.5 in all 
patients. Only superficial punctate keratopathy was observed 
as a perioperative complication in two eyes 1 week postop-
eratively and in one eye 1 month postoperatively. Figure 1 
shows the correlation between the MMP-9 activity and C4S 
concentration in the tear fluid. The preoperative correlation 
was high (r = 0.900; P , 0.001), but it disappeared at post-
operative month 1. Although a correlation was present at Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Figure 1 Correlation of matrix metalloproteinase-9 (MMP-9) activity and Chondroitin 4 sulfate (C4S) concentrations at each time point with (A) preoperative score (r = 0.900; 
P , 0.001), (B) postoperative day 1(r = 0.621; P , 0.05), (C) postoperative day 4 (r = 0.694; P , 0.05), (D) postoperative week 1 (r = 0.801; P , 0.01), (E) postoperative 
month 1, and (F) postoperative month 3 (r = 0.730; P , 0.05). r = correlation coefficient.
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postoperative days 1 (r = 0.621; P , 0.05) and 4 (r = 0.694; 
P , 0.05), 1 week (r = 0.801; P , 0.01) and 3 months 
(r = 0.730; P , 0.05), it was weaker than was found preop-
eratively. Figure 2 shows the correlation between the MMP-9 
activity and C6S concentration in the tear fluid. The preop-
erative correlation was high (r = 0.885; P , 0.001), but was 
not present at postoperative week 1, or at months 1 and 3. 
Although the correlation existed at postoperative days 1 
(r = 0.787; P , 0.01) and 4 (r = 0.625; P , 0.05), it was lower 
than the preoperatively measured score just as C4S.
Discussion
The correlation changed between the MMP-9 activity 
and CS concentrations before and after LASIK. There Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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was high correlation between the MMP-9 activity and CS 
  concentrations preoperatively. When the ocular surface is 
normal before surgery, the MMP-9 activity and CS concen-
trations are well correlated, and the environment is stable. 
However, this correlation disappeared or declined after 
LASIK. We hypothesized that this change was caused by 
LASIK, and the correlation between the MMP-9 activity 
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Figure 2 Correlation of matrix metalloproteinase-9 (MMP-9) activity and Chondroitin 6 sulfate (C6S) concentrations at each time point with (A) preoperative score 
(r = 0.885; P , 0.001), (B) postoperative day 1 (r = 0.787; P , 0.01), (C) postoperative day 4 (r = 0.625; P , 0.05), (D) postoperative week 1, (E) postoperative month 1, and 
(F) postoperative month 3. r = correlation coefficient.
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and CS   concentrations did not recover to the preoperative 
levels even by 3 months following LASIK. These results 
indicated that the corneal wound healing did not terminate 
at 3 months after LASIK. A study in rabbits reported that 
material positive for periodic acid Schiff and disorganized 
collagen fibers were even seen 9 months after LASIK, and 
the corneal wound healing still had not ceased.14 From these Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
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findings, it is likely that the corneal wound healing lasts for a 
long period following LASIK, implying that the insufficient 
attachment between the corneal flap and the corneal bed 
lasts for a prolonged period. There were a few subjects in 
which the dislocation of corneal flaps,15,16 or ectasia which 
consisted of a progressive deformation and thining of the 
cornea12 after LASIK, and these cases appear to be related 
to corneal wound healing. Although no case of either a dis-
location of corneal flaps or ectasia has occurred so far, there 
is a possibility for such an occurrence. We must therefore 
carefully observe all patients who undergo LASIK for a 
long period of time.
To evaluate the MMP-9 and CS isomers, we chose 
patients undergoing LASIK partly because there have been 
no previous studies of perioperative MMP-9 activity and 
CS concentrations in the tear fluid in that series. In addition, 
many more patients have recently undergone LASIK. Finally, 
the cornea after LASIK is seriously injured and may be a 
good model of corneal wound healing.
We used topical corticosteroids in the present study, 
which may be a factor that affected the corneal wound 
healing. Topical corticosteroids might affect the change in 
MMP-9 activity and CS concentrations and thereby impact 
corneal wound healing. However, there was not a great effect 
on the refraction stability or the occurrence of diffuse lamellar 
keratitis,17,18 and the beneficial effects of topical corticoster-
oids are limited for corneal wound healing.5
According to Sobrin et al, MMP-3 independently activated 
MMP-9 on the ocular surface, and doxycycline decreased 
MMP-9 activity in corneal epithelial cultures.8 Zylberberg et al 
found that both pro-MMP-2 and pro-MMP-9 were secreted 
by the lacrimal gland, and were likely up-  regulated by estro-
gen.19 Kobayashi reported that leptomycin B reduced MMP-9 
expression.4 During corneal wound healing, transforming 
growth factor-β and MMPs are involved in the synthesis and 
decomposition of the extracellular matrix.20,21 Taken together, 
MMPs interact with many factors by complex mechanisms, 
are well balanced with each other, and have important roles 
in the corneal wound-healing process.
Although the preoperative MMP-9 activity and CS 
  concentrations were highly correlated, we found that this 
  correlation disappeared or declined after LASIK in the   present 
series. The corneal wound healing may require 3 months or 
more following LASIK because the correlation did not recover 
to the preoperative correlation levels at 3 months after the 
procedure. Clarifying the correlation between MMP-9 and 
CS may elucidate or aid in the prevention of dislocation of 
corneal flaps and ectasia following LASIK.
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